Login

Interview with Genasys CEO Richard S. Danforth on company developments and industry insights. 00:10:00

Share On Facebook Share On Twitter

Richard S. Danforth is the CEO of Genasys.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease|Joe Todisco,Chief Executive Officer,CorMedix Inc
00:10:00
Gabriele Solarini Paviotti, account relationship leader at Auxiell, interviews Gianmarco Lanza, President and CEO of FAE Technology.
00:10:00
Private Equity Fund Essentials: Insights from Simpson Thacher Experts | Alden Millard - Partner,Chair of the Executive Committee of Simpson Thacher
00:10:00
Developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products|Klaus Paulini,CEO,AEterna Zentaris Inc
00:10:00
Understanding Bernstein Private Wealth Management: Insights with Michael Lopes, VP
00:10:00
Introducing GOVERN Function and Enhanced Framework Functions | Domenico Favuzzi, President & CEO of Exprivia SpA
00:10:00
Christophe Bavière Discusses Private Equity Strategy and Market Adaptation | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
PIMCO CIO Dan Iverson's Take on the Current Market Environment and Bond Investing | Dan Iverson, CIO, PIMCO.
00:10:00
"Donald Yacktman Discusses Investment Strategies: High-Quality Stocks as the Best Value Opportunity on Bloomberg"
00:10:00
Focused on interactive content and technology companies|Sam Englebardt,Co-Founder and General Partner,Galaxy Interactive
00:10:00
Meet Kendall King, CFP®, AEP®: Founder and Leader at Castlepoint Wealth Advisors
00:10:00
Avjet: Video of company presentation and client endorsements | Denis Jacob, President and CEO, Avjet Holding Inc. (TS)

© 2017 - Neuhu+